PATENT CLAIM ANALYSIS

Application Number: 15742710
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "174000"]

Abstract:
Disclosed is a storage-stable pharmaceutical formulation for rectal administration, containing budesonide or a pharmaceutically compatible salt or derivative thereof, and at least 80 wt % of a solid fat or a mixture of different solid fats, based on the total weight of the formulation, as well as at least one anti-oxidation agent that is compatible therewith.

Claim (Index 14):
A pharmaceutical formulation according to  claim 1  for use in the treatment of inflammatory diseases of the rectum.

Metadata:
- Claim Count in Document: 36.0
- Percentile: 86.0
- Lexical Diversity: 1.4186
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12476185', '12639645', '12245648', '15555325', '12609845']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7612199993287385
- 35 USC 102 Novelty (BERT): 0.4849752167557596
- Combined Prediction Score: 0.7335955210714407
- Mean Citation Score: 172.401196
- Max Citation Score: 183.86
- Similarity Product: 131.40653624534608

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test